Dong Peixin

J-GLOBAL         Last updated: Sep 17, 2019 at 12:48
 
Avatar
Name
Dong Peixin
E-mail
dpx1cngmail.com
Affiliation
Hokkaido University
Section
School of Medicine
Research funding number
50602504
Google Analytics
UA-63220513-1
ORCID ID
0000-0002-2335-1394

Research Areas

 
 

Education

 
Oct 1992
 - 
Sep 1997
M.D., Medicine, Harbin Medical University, China
 

Committee Memberships

 
Apr 2010
 - 
Today
Hokkaido Society of Obstetrics & Gynecology
 
Apr 2010
 - 
Today
Japan Society of Obstetrics & Gynecology
 

Awards & Honors

 
Feb 2016
Hokkaido University President's Award for Outstanding Research (February 3, 2016)
 
Oct 2012
The 92nd Hokkaido Medical Congress Award
 

Published Papers

 
Peixin Dong, Ying Xiong, Junming Yue, Daozhi Xu, Kei Ihira, Yosuke Konno, Noriko Kobayashi, Yukiharu Todo, Hidemichi Watari
Journal of Experimental & Clinical Cancer Research   38(1)    Dec 2019   [Refereed]
Xu D, Dong P, Xiong Y, Yue J, Ihira K, Konno Y, Kobayashi N, Todo Y, Watari H
Cancers      Aug 2019   [Refereed]
<jats:p>MicroRNA-361-5p (miR-361) expression frequently decreases or is lost in different types of cancers, and contributes to tumor suppression by repressing the expression of its target genes implicated in tumor growth, epithelial-to-mesenchymal...
Zhao G, Wang Q, Wu Z, Tian X, Yan H, Wang B, Dong P, Watari H, Pfeffer LM, Guo Y, Li W, Yue J
Molecular Cancer Therapeutics      Sep 2019   [Refereed]
Peixin Dong, Ying Xiong, Junming Yue, Sharon J. B. Hanley, Noriko Kobayashi, Yukiharu Todo, Hidemichi Watari
Cancers   11(2) 234   Feb 2019   [Refereed]
Dong P, Xiong Y, Yue J, Hanley SJB, Watari HDong P, Xiong Y, Yue J, Hanley SJB, Watari H
Front. Oncol.      Sep 2018   [Refereed]
Wang B, Li X, Zhao G, Yan H, Dong P, Watari H, Sims M, Li W, Pfeffer LM, Guo Y, Yue J
J Exp Clin Cancer Res      Sep 2018   [Refereed]
Dong P, Xiong Y, Yue J, Hanley SJB, Watari H
Oncotarget      May 2018   [Refereed]
Dong P, Xiong Y, Yue J, Hanley SJB, Watari H
   Jul 2018   [Refereed]
Dong P, Xiong Y, Yu J, Chen L, Tao T, Yi S, Hanley SJB, Yue J, Watari H, Sakuragi N
Oncogene      May 2018   [Refereed]
Aoyama-Kikawa S, Fujita H, Hanley SJB, Kasamo M, Kikuchi K, Torigoe T, Matsuno Y, Tamakoshi A, Sasaki T, Matsuura M, Kato Y, Dong P, Watari H, Sakuragi N
Cancer science      Apr 2018   [Refereed]
Zhang T, Zhao G, Yang C, Dong P, Watari H, Zeng L, Pfeffer L.M, Yue J.
Oncology Letters   15(4) 4432-4438   Apr 2018   [Refereed]
Xiong Y, Sun F, Dong P, Watari H, Yue J, Yu MF, Lan CY, Wang Y, Ma ZB
Journal of Experimental & Clinical Cancer Research   36(1) 48   Apr 2017   [Refereed]
Zhang Q, Dong P, Liu X, Sakuragi N, Guo SW
Scientific reports   7(1) 6804   Jul 2017   [Refereed]
Zhao G, Wang Q, Gu Q, Qiang W, Wei JJ, Dong P, Watari H, Li W, Yue J.
   Oct 2017   [Refereed]
Dong P, Xiong Y, Hanley SJB, Yue J, Watari H
Journal of experimental & clinical cancer research : CR      Oct 2017   [Refereed]
Ihira K, Dong P, Xiong Y, Watari H, Konno Y, Hanley SJ, Noguchi M, Hirata N, Suizu F, Yamada T, Kudo M, Sakuragi N
Oncotarget   8(8) 13509-13520   Feb 2017   [Refereed]
Hanley SJ, Fujita H, Tamakoshi A, Dong P, Sakuragi N, The Lancet. Oncology, vol. 17, no. 9, pp. e372
The Lancet. Oncology   17(9) e372   Sep 2016   [Refereed]
Hanley SJ, Fujita H, Tamakoshi A, Dong P, Sakuragi N, The Lancet. Oncology, 2016, vol. 17, no. 9, pp. e372, 2016
Dong P, Xiong Y, Watari H, Hanley SJ, Konno Y, Ihira K, Suzuki F, Yamada T, Kudo M, Yue J, Sakuragi N
Scientific reports   6    Oct 2016   [Refereed]
Sci Rep. 2016 Oct 21;6:35480.
Huo W, Zhao GGuannan, Yin J, Ouyang X, Wang Y, Yang C, Wang B, Dong P, Wang Z, Watari H, Chaum E, Pfeffer L.M, Yue J.
Journal of Cancer   8(1) 57-64   2017   [Refereed]
Dong P, Xiong Y, Watari H, Hanley SJ, Konno Y, Ihira K, Yamada T, Kudo M, Yue J, Sakuragi N
Journal of experimental & clinical cancer research   35(1) 132   Sep 2016   [Refereed]
Dong P, Xiong Y, Watari H, Hanley SJ, Konno Y, Ihira K, Yamada T, Kudo M, Yue J, Sakuragi N, Journal of experimental & clinical cancer research : CR, 2016, vol. 35, no. 1, pp. 132, 2016
Hanley SJ, Fujita H, Yokoyama S, Kunisawa S, Tamakoshi A, Dong P, Kobayashi N, Watari H, Kudo M, Sakuragi N, Journal of medical screening, vol. 23, no. 3, pp. 164-170
Journal of medical screening   23(3) 164-170   Sep 2016   [Refereed]
Hanley SJ, Fujita H, Yokoyama S, Kunisawa S, Tamakoshi A, Dong P, Kobayashi N, Watari H, Kudo M, Sakuragi N, Journal of medical screening, 2016, vol. 23, no. 3, pp. 164-170, 2016
Dong P, Ihira K, Xiong Y, Watari H, Hanley SJ, Yamada T, Hosaka M, Kudo M, Yue J, Sakuragi N
Oncotarget   7(15) 20260-20270   Apr 2016   [Refereed]
Dong P, Ihira K, Xiong Y, Watari H, Hanley SJ, Yamada T, Hosaka M, Kudo M, Yue J, Sakuragi N, Oncotarget, 2016
Cancer Medicine & Anti Cancer Drugs      Apr 2016   [Refereed]
Wang B, Shen A, Ouyang X, Zhao G, Du Z, Huo W, Zhang T, Wang Y, Yang C, Dong P, Watari H, Pfeffer LM, Yue J
Biochemical and biophysical research communications   484(3) 486-492   Mar 2017   [Refereed]
Dong Peixin, Ihira Kei, Hamada Junichi, Watari Hidemichi, Yamada Takahiro, Hosaka Masayoshi, Hanley Sharon J. B, Kudo Masataka, Sakuragi Noriaki
Oncotarget   6(24) 19968-19975   2015   [Refereed]
MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells
Konno Y, Dong P, Xiong Y, Suzuki F, Lu J, Cai M, Watari H, Mitamura T, Hosaka M, Hanley SJ, Kudo M, Sakuragi N
Oncotarget   5(15)    Aug 2014   [Refereed]
Dong P, Konno Y, Watari H, Hosaka M, Noguchi M, Sakuragi N
J Transl Med   12(1)    Aug 2014   [Refereed]
Dong P, Kaneuchi M, Watari H, Sudo S, Sakuragi N
Mol Carcinog   53(5) 349-359   May 2014   [Refereed]
Dong P, Kaneuchi M, Xiong Y, Cao L, Cai M, Liu X, Guo SW, Ju J, Jia N, Konno Y, Watari H, Hosaka M, Sudo S, Sakuragi N
Carcinogenesis   35(4) 760-768   Apr 2014   [Refereed]
Dong P.
Current Approaches to Endometrial Cancer   182-199   2014   [Refereed]
Dong P, Karaayvaz M, Jia N, Kaneuchi M, Hamada J, Watari H, Sudo S, Ju J, Sakuragi N
Oncogene   32(27) 3286-3295   Jul 2013   [Refereed]
Konno Yosuke, Dong Peixin, Xiong Ying, Suzuki Fumihiko, Lu Jiabin, Cai Muyan, Watari Hidemichi, Mitamura Takashi, Hosaka Masayoshi, Hanley Sharon J. B, Kudo Masataka, Sakuragi Noriaki
Oncotarget   5(15) 6049-6062   2014   [Refereed]
Dong P, Kaneuchi M, Konno Y, Watari H, Sudo S, Sakuragi N
Biomed Res Int   2013    2013   [Refereed]
Watari H, Dong P, Mitamura T, Fujita H, Sakuragi N.
Current Approaches to Endometrial Cancer   34-45   2014   [Refereed]
Odagiri Tetsuji, Watari Hidemichi, Kato Tatsuya, Mitamura Takashi, Hosaka Masayoshi, Sudo Satoko, Takeda Mahito, Kobayashi Noriko, Dong Peixin, Todo Yukiharu, Kudo Masataka, Sakuragi Noriaki
Annals of Surgical Oncology   21(8) 2755-2761   2014   [Refereed]
Jia N, Dong P, Ye Y, Qian C, Dai Q
Cardiovascular therapeutics   30(2) 117-123   Apr 2012   [Refereed]
Mitamura T, Watari H, Wang L, Kanno H, Miyazaki M, Kitagawa M, Hassan M.K, Dong P, Kimura T, Tanino M, Nishihara H, Tanaka S, Sakuragi N.
Molecular Cancer   13(1)    2014   [Refereed]
Dong P, Kaneuchi M, Watari H, Hamada J, Sudo S, Ju J, Sakuragi N
Mol Cancer   10 99   Aug 2011   [Refereed]
Jia N, Dong P, Huang Q, Jin W, Zhang J, Dai Q, Liu S
Clinical and experimental pharmacology & physiology   36(3) 262-266   Mar 2009   [Refereed]
Zhai H, Karaayvaz M, Dong P, Sakuragi N, Ju J.
Biomark Res      2013   [Refereed]
Dong PX, Jia N, Xu ZJ, Liu YT, Li DJ, Feng YJ
J Exp Clin Cancer Res   27(1)    2008   [Refereed]
Dong P, Tada M, Hamada J, Nakamura A, Moriuchi T, Sakuragi N
Clin Exp Metastasis   24(6) 471-483   2007   [Refereed]
Kato Tatsuya, Watari Hidemichi, Endo Daisuke, Mitamura Takashi, Odagiri Tetsuji, Konno Yousuke, Hosaka Masayoshi, Kobayashi Noriko, Todo Yukiharu, Sudo Satoko, Takeda Mahito, Dong Peixin, Kaneuchi Masanori, Kudo Masataka, Sakuragi Noriaki
Journal of Surgical Oncology   106(8) 938-941   2012   [Refereed]
Dong P, Nabeshima K, Nishimura N, Kawakami T, Hachisuga T, Kawarabayashi T, Iwasaki H
Cancer Lett.   243(1) 120-127   Nov 2006   [Refereed]

Misc

 
金野陽輔, 董培新, 鈴木史彦, 櫻木範明
日本婦人科腫よう学会雑誌   33(3) 535   Jun 2015
金野陽輔, 董培新, 鈴木史彦, 櫻木範明
日本産科婦人科学会雑誌   67(2) 542   Feb 2015
董培新, 渡利英道, 水上尚典, 桜木範明
日本産科婦人科学会雑誌   58(2) 400   Feb 2006
董培新, 渡利英道, 蝦名康彦, 山本律, 水上尚典, 桜木範明
日本産科婦人科学会雑誌   57(2) 448   Feb 2005

Books etc

 
Endometrial cancer
Dong Peixin (Part:Joint Work, Chapter 10 – Molecular targets and targeted therapy)
Future Science Group, London, UK   Apr 2014   
Recent progress in molecular pathology of two types of endometrial cancer (EC) (type I endometrioid, and type II poorly differentiated endometrioid and serous) have permitted the identification of differentially expressed genes and aberrant signal...

Conference Activities & Talks

 
Epigenetic aspects of endometrial cancer progression: Insights into interactions of EZH2 and microRNAs [Invited]
Dong Peixin
The 4th International Obstetrics & Gynecology Summit · The Red House Forum   4 Jun 2017   
Reactivating the expression of silenced miR-124 for endometrial cancer treatment [Invited]
Dong Peixin
The 7th Annual World Gene Convention-2016   5 Nov 2016   
Targeting EZH2-miR-361-Twist axis in endometrial cancer [Invited]
Dong Peixin
The 6th Annual World Congress of Molecular & Cell Biology   26 Apr 2016   
EZH2 Stimulates Twist Expression by Epigenetic Silencing of Its Suppressor miR-361 through an YY1-dependent Mechanism
Dong Peixin
The 8th World Congress of Regenerative Medicine & Stem Cell   20 Nov 2015   
MicroRNA-101 attenuates Twist1 expression by induction of its negative regulator miR-361-5p through an EZH2-dependent mechanism
Dong Peixin
The 67th JSOG   10 Apr 2015   
Identification of KLF17 as a novel epithelial to mesenchymal transition inducer via direct activation of TWIST1 in endometrioid endometrial cancer
Dong Peixin
The FEBS EMBO 2014 Conference   2 Sep 2014   
Identification of KLF17 as a novel epithelial to mesenchymal transition inducer via direct activation of TWIST1 in endometrioid endometrial cancer
Dong Peixin
The 3rd ASGO Meeting   14 Dec 2013   
MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines
Dong Peixin
The 12th Meeting of Molecular Targeted Therapy in Gynecologic Cancers   6 Jul 2013   
Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis
Dong Peixin
The 65th JSOG   10 May 2013   
MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines
Dong Peixin
The 25th Hokkaido Cancer Treatment Research Meeting   23 Mar 2013   
Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis
Dong Peixin
The 3rd International Cancer Epigenetics Meeting   13 Oct 2012   
MicroRNA-194, a tumor suppressor microRNA that regulates epithelial to mesenchymal transition and endometrial cancer cell invasion
Dong Peixin
The 5th World Cancer Congress (WCC-2012)   19 May 2012   
Identification of miR-194 as a key suppressor of epithelial to mesenchymal transition in endometrial cancer
Dong Peixin
The 1st World Congress of Small RNAs   5 Nov 2011   
MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting BMI-1
Dong Peixin
The 17th International Meeting of the European Society of Gynaecological Oncology (ESGO 2011)   12 Sep 2011   
MiR-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting BMI-1
Dong Peixin
The 50th Meeting of Japan Society of Gynecologic Oncology   24 Jul 2011   
MicroRNA-106b suppresses epithelial to mesenchymal transition of endometrial cancer cells by targeting IQGAP1
Dong Peixin
The 10th Meeting of Molecular Targeted Therapy in Gynecologic Cancers   2 Jul 2011   
Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway
Dong Peixin
The 13th Biennial Meeting of the International Gynecologic Cancer Society (IGCS 2010)   25 Oct 2010   
p53 dominant-negative mutation R273H promotes tumor invasion in endometrial adenocarcinoma cell line HHUA
Dong Peixin
The 100th American Association for Cancer Research Annual Meeting (AACR)   17 Apr 2007   
Functional analysis of p53 status and the prognostic impact of dominant-negative p53 mutation in endometrial cancer
Dong Peixin
The 57th Annual Congress of the Japan Society of Obstetrics and Gynecology (JSOG)   4 Apr 2005   

Social Contribution

 
Guest editor
[Others]  Cancers  1 Feb 2019